Results 1 to 10 of about 3,252,030 (129)

Detection of Porcine Respirovirus 1 (PRV1) in Poland: Incidence of Co-Infections with Influenza A Virus (IAV) and Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) in Herds with a Respiratory Disease [PDF]

open access: goldViruses, 2022
Porcine respirovirus 1 (PRV1) is also known as porcine parainfluenza virus 1 (PPIV1). The prevalence and the role of PRV1 infections for pig health is largely unknown.
Aleksandra Woźniak   +4 more
doaj   +6 more sources

Emergence of swine influenza A virus, porcine respirovirus 1 and swine orthopneumovirus in porcine respiratory disease in Germany [PDF]

open access: yesEmerging Microbes and Infections, 2023
Respiratory disease is a significant economic issue in pig farming, with a complex aetiology that includes swine influenza A viruses (swIAV), which are common in European domestic pig populations.
Annika Graaf-Rau   +10 more
doaj   +3 more sources

Identification of β4GALNT2 as an anti-hPIV3 factor through genome-wide CRISPR/Cas9 library screening [PDF]

open access: yesEmerging Microbes and Infections
Human respirovirus 3 (also known as human parainfluenza virus 3; hPIV3) is a major cause of severe acute respiratory infections in vulnerable populations.
Xuesheng Wu   +10 more
doaj   +3 more sources

Presence and Characterisation of Porcine Respirovirus 1 (PRV1) in Northern Italy [PDF]

open access: yesPathogens
Porcine Respirovirus 1 (PRV1) is an enveloped, single-stranded, negative-sense RNA virus belonging to the genus Respirovirus within the Paramyxoviridae family.
Enrica Sozzi   +13 more
doaj   +3 more sources

Genetic diversity and evolutionary analysis of human respirovirus type 3 strains isolated in Kenya using complete hemagglutinin-neuraminidase (HN) gene.

open access: yesPLoS ONE, 2020
Human respirovirus type 3 (HRV3) is a leading etiology of lower respiratory tract infections in young children and ranks only second to the human respiratory syncytial virus (HRSV).
Juliet Elusah   +4 more
doaj   +2 more sources

Structural basis for potent neutralization of human respirovirus type 3 by protective single-domain camelid antibodies

open access: yesNature Communications
Respirovirus 3 is a leading cause of severe acute respiratory infections in vulnerable human populations. Entry into host cells is facilitated by the attachment glycoprotein and the fusion glycoprotein (F).
Nicole V. Johnson   +8 more
doaj   +2 more sources

Multicenter evaluation of the QIAstat Respiratory Panel-A new rapid highly multiplexed PCR based assay for diagnosis of acute respiratory tract infections.

open access: yesPLoS ONE, 2020
Acute respiratory tract infections (ARTI), including the common cold, pharyngitis, sinusitis, otitis media, bronchiolitis and pneumonia are the most common diagnoses among patients seeking medical care in western countries, and account for most ...
Marijo Parčina   +5 more
doaj   +2 more sources

The virome composition of respiratory tract changes in school-aged children with Mycoplasma pneumoniae infection [PDF]

open access: yesVirology Journal
Background Mycoplasma pneumoniae (MP) is a common pathogen for respiratory infections in children. Previous studies have reported respiratory tract microbial disturbances associated with MP infection (MPI); however, since the COVID-19 pandemic ...
Dianqi Zhang   +8 more
doaj   +2 more sources

Characterization of viral pathogens associated with symptomatic upper respiratory tract infection in adults during a low COVID-19 transmission period [PDF]

open access: yesPeerJ, 2023
Background The epidemiology of respiratory tract infections (RTI) has dramatically changed over the course of the COVID-19 pandemic. A major effort in the clinical management of RTI has been directed toward diagnosing COVID-19, while the causes of other,
Nurlan Sandybayev   +5 more
doaj   +2 more sources

[Intranasal vaccine against COVID-19 based on a recombinant variant of the Sendai virus (Paramyxoviridae: Respirovirus) strain Moscow].

open access: yesVoprosy virusologii, 2023
INTRODUCTION Intranasal vaccination using live vector vaccines based on non-pathogenic or slightly pathogenic viruses is the one of the most convenient, safe and effective ways to prevent respiratory infections, including COVID-19.
G. Kudrov   +12 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy